Study: US 2021, JAMA

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Citation

US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM et al (2021). JAMA. PubMed id 34003218.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Bowel (colon) cancer screening Tier B moderate

    B Asymptomatic adults aged 45 or over at average risk, US; the review also examined whether findings varied by age, sex or race/ethnicity (n=not stated in the abstract)

    US Preventive Services Task Force recommendation statement based on a commissioned systematic review and modelling.

    High certainty that screening aged 50 to 75 has substantial net benefit; moderate certainty that screening at 45 to 49 has moderate net benefit. About 10.5% of new US colorectal cancers are in people under 50, and incidence in 40 to 49 year olds rose by almost 15% between 2000-2002 and 2014-2016. The abstract does not report results by race.

    As recorded in this card: US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM et al (2021), JAMA, [consensus]

    Note: General US population, not Black-specific; the abstract states the review looked at race/ethnicity but gives no result.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.